Archive | Longevity & Age-Tech RSS feed for this section

Winners of Digital RESI June 2021 Innovator’s Pitch Challenge (IPC)

17 Jun

By Claire Jeong, Chief Conference Officer, Vice President of Investor Research, Asia BD, LSN

claire

Digital Redefining Early Stage Investments (RESI) June ended on a high note last week, again providing a valuable platform for early-stage life science companies and investors/strategic partners to connect and start dialogue.

This RESI also featured the largest number of Innovator’s Pitch Challenge companies, with almost fifty companies participating. Each company was assigned to one of ten live Q&A sessions featuring investors and industry partners, based on sector/technology.

Attendees voted for their favorite companies throughout the three days of the conference. Check out the winners below!

1st Place – Throne Biotechnologies

Throne is an American therapeutics company aimed at commercializing a novel stem cell technology that can fundamentally reverse diabetes, alopecia areata and other autoimmune diseases through immune education. The patented technology is recognized as the leading “practical cure project” for type 1 diabetes among 594 global projects (JDCA 2020). Stem Cell Educator therapy is a single dialysis-like treatment that fundamentally “resets” a patient’s immune system and corrects the underlying autoimmunity. 200+ patients between the ages of 3 and 70 have been treated in 10 years of clinical research in Spain, China, and US. 70% of type 1 and type 2 diabetic patients demonstrated clinical efficacy. Many patients reduced insulin dosing and some have become insulin independent. This technology has been successfully tried in more than 10 autoimmune diseases including alopecia, lupus, fibrosis, and scleroderma. This therapy is ready to use and is approved to begin three FDA phase 2 clinical trials (type 1 diabetes, alopecia areata, COVID-19). Throne is looking to raise $5M to complete US FDA phase 2 through to commercialization. Throne is open to partnerships, joint ventures, investments, and license arrangements.

2nd Place – Praetego

Praetego is a pre-clinical stage pharmaceutical company with a mission to improve the health and longevity of diabetic patients. Praetego is developing novel small molecules (Amadorins) to alleviate serious diabetic complications, starting with peripheral neuropathy. Amadorins are first-in-class molecules able to inhibit a primary driver of diabetic microvascular disease and are derived from a clinically proven prototype.

3rd Place – Nano PharmaSolutions

A proprietary drug delivery nanotechnology that generates poorly soluble drugs as nanoparticles for better bioavailability. Our NanoTransformer(TM) technology can generate drug nanoparticles through phase transfer method without using any chemicals or solvent. We work with (1) preclinical stage drug developers for animal study formulations and (2) innovative generic companies for generic nanodrug development. We are at revenue stage and our revenue forecast is $150M in 2026 (our target exit time frame).

Congratulations to each of the winners, who have received free tickets to future RESI conferences to boost their fundraising efforts. Thank you to all finalists, judges, and attendees who make the IPC an exciting and powerful part of RESI! Interested in joining a future IPC? Applications are open for RESI Partnering Week September, featuring three separate RESI conferences! Select the logos below to learn more!

Apply for RESI IPC
Sept.13-15
Apply for RESI AI IPC
Sept.16-17
Apply for RESI Longevity IPC
Sept.16-17

Super early bird rates apply until July 9. Sign up now to save $100!

Panels at RESI Partnering Week September 13-17, 2021

17 Jun

By Rory McCann, Marketing Manager & Conference Producer, LSN

RESI Partnering Week returns September 13-17 and attendees can save $100 when they register by July 9! RESI Partnering Week is a five-day digital partnering experience connecting early-stage entrepreneurs in drugs, devices, diagnostics, and digital health with active investors who are a fit for their product and stage of development.

The RESI creators at Life Science Nation (LSN) understand that partnering is a multi-faceted process that takes time and commitment to yield fruitful relationships that turn into strategic partnerships. We offer several programs for attendees to take advantage of in order to optimize their experience, including our interactive panels that feature prominent life science and healthcare investors, as well as fundraising executives with their own tales from the road.

resi-sept-logo

  • Angels & Family Offices
  • Asia Cross Border
  • Big Pharma
  • Corporate VC
  • Medical Devices
  • Mental & Behavioral Health
  • Seed Funds
  • Tales from the Road

resi-ai-sept

  • Healthcare Communications
  • Reproductive Wellness
  • Healthcare Systems and Infrastructure
  • Accelerated Pharmaceutical Development
  • Diagnostic Wearables
  • Precision Medicine

resi-longevity-sept

  • Social Isolation & Loneliness
  • Health & Home Care
  • Medical Accountability & Adherence
  • Sensory Wellness

Contact us to learn more about RESI Partnering Week and how we can tailor the experience to meet your partnering needs.

For a demo, or to see how many investors in our a database are interested in your product, feel free to schedule a time that works best for you via LSN BD team’s Calendly link below.
International & MA (USA) West Coast (USA) East Coast (USA) & Canada Midwest (USA)
Greg Mannix
Vice President International Business Development
Schedule a call with me!
Candice He
Director of Pacific Region & Global Investment Strategist
Schedule a call with me!
Elizabeth Murphy
Manager of Business Development
Schedule a call with me!
Antoinette Lowre
Manager of Business Development
Schedule a call with me!

RESI Partnering Week Returns September 13-17

10 Jun

By Rory McCann, Marketing Manager & Conference Producer, LSN

RESI Partnering Week (RPW) returns September 13-17 for five days of match-based partnering, educational workshops, expert panels, innovative pitch sessions, and more!

RPW features a unique model made up of three days of Digital Redefining Early Stage Investments (RESI), followed by two days of targeted partnering and unique content designed specifically for age-tech and AI technology.

Get to know each event to see which are a fit for you! Super early bird rates are available until July 9, so register today to SAVE!

Redefining Early Stage Investments (RESI)

September 13-15, 2021

resi-sept-logoThe Redefining Early Stage Investments (RESI) conference series brings together startups with early-stage investors and strategic channel partners to maximize the capability of these companies, from seed to series B, to find partners who are a fit for their technology and stage of development. RESI is cross-border and cross-domain, connecting start-ups with ten categories of global investors across the silos of drugs, devices, diagnostics, and digital health. RESI caters to both the earliest stage startups, those seeking grants, seed and angel capital, and the early-stage firms who seek seed, series A, and B funding.

RESI AI

September 16-17, 2021

resi-ai-septArtificial intelligence (AI) is rapidly reshaping the healthcare landscape and redefining what is possible in life science. RESI AI is a digital partnering conference that connects the investors and strategic partners and matches them to companies developing and commercializing AI technology in drugs, devices, diagnostics, and digital health to revolutionize healthcare. RESI AI features investors and entrepreneurs sharing their experiences in early-stage funding and what makes a successful partnership. This two-day digital conference provides the opportunity to meet and learn from experts, build relationships, and advance healthcare through the power of AI.

RESI Longevity

Co-Organized with Mary Furlong & Associates
September 16-17, 2021

resi-longevity-septThe aging boomer population contributed $8.3 trillion in economic activity to the 2018 US economy, and that number is projected to triple by 2050. The need for advancements in drugs, devices, diagnostics, and digital health for the treatment of age-related conditions is crucial. RESI Longevity is a new partnering conference focused on conditions related to aging, market challenges, and solutions via early-stage companies and their promising tech and products. RESI Longevity brings fundraising startups together with investors in age-tech innovation to make deals in order that today’s seniors live longer, healthier lives.

Learn more about what to expect at each event and how you can get involved!

1:1 Partnering

handshack_icon

The investors attending RESI represent a huge pool of capital, and Life Science Nation (LSN)’s unique partnering system enables fundraising companies find the investors and strategic partners that are a best fit for their technology and stage of development.

  • Review profiles of other participants.
  • Schedule one-on-one and/or group meetings.
  • Build your customized conference schedule, from panels to presentations to partnering meetings

Investor Panels & Workshops

panels_icon_new

Panels and workshops highlight panelists who can provide their perspective on current trends, as well as valuable advice to fundraising start-ups. From big corporations to angel groups, and from established VCs to family offices, the panelists participating at RESI reflect LSN’s global investor network. Panels will be live-streamed, giving audience members a chance to get their questions answered in real-time.

Innovator’s Pitch Challenge

ipc_icon_new

The Innovator’s Pitch Challenge (IPC) is an opportunity for early-stage companies to gain additional exposure to conference attendees, pitch directly to a panel of relevant investors, and participate in a live Q&A session. Participating companies pay registration and a pitching fee to host their company materials on the Live Agenda and participate in the live pitch session.

Apply for RESI IPC
Sept.13-15
Apply for RESI AI IPC
Sept.16-17
Apply for RESI Longevity IPC
Sept.16-17

Virtual Exhibit Hall

exhibitor hall

Exhibitors and sponsors will be featured on a dedicated page with a virtual exhibitor booth, showcasing their services and the value they can provide. Participating tech hubs can highlight their programs and constituent companies.

Stories for a New Age

6 May

By Rory McCann, Marketing Manager & Conference Producer, LSN

When LifeBio Founder and CEO, Beth Sanders started telling stories, she knew how influential they could be. Today, patients and healthcare providers are using LifeBio’s storytelling platform to connect, decrease loneliness, and promote better care and overall wellness.

LifeBio was a winner at the March Innovator’s Pitch Challenge at Longevity, Health & Innovation (now RESI Longevity). Registration for RESI Longevity (September 16-17) is now open at super early bird rates until July 23, and applications for the next Innovator’s Pitch Challenge are open!

Listen to our conversation with Beth on the origin and mission of LifeBio, and how stories are having a strong impact on today’s seniors and the healthcare system.

Introducing RESI AI and RESI Longevity

22 Apr

By Caitlin Dolegowski, Marketing Specialist, LSN

Caiti

Life Science Nation (LSN) renames its two newest conferences under the Redefining Early Stage Investments (RESI) banner. This conference series has provided early-stage life science entrepreneurs a space dedicated to their fundraising efforts through connecting them with partners and capital that are a fit for their product and stage of development. Through the years, LSN has worked with thousands of executives in their search for partnerships, and the secret has always been that it all comes down to finding that right fit. In order to help target these elusive matches, LSN spun two sister conferences, 4D Meets AI and Longevity, Health and Innovation, now RESI AI and RESI Longevity respectively, out of the RESI conference series, designed to further narrow down the early-stage life science players, based on technology and indication.

4D Meets AI has focused on connecting entrepreneurs using AI technology to advance drugs, devices, diagnostics, and digital health (4Ds) with investors and partners actively seeking AI applications in their themes and portfolios. Longevity, Health & Innovation, co-organized with Mary Furlong & Associates, is a space for fundraising executives targeting diseases that disproportionately affect aging populations to connect with capital and resources specifically in age-tech.

These two conferences are designed to create a more intimate atmosphere within the RESI partnering ecosystem. Each invites a unique attendee, yet both are a digital partnering conferences advancing the mission of the RESI series – to connect technology in life science and health care with well-fitting capital and channel partners – which is why they return this fall as RESI AI and RESI Longevity.

RESI Longevity and RESI AI both take place September 16-17 as two-day digital partnering conferences. Each will feature their own unique lineups of Investor Panels, Educational Workshops, Innovator’s Pitch Challenges and Premier Partnering Platforms. Learn more about each conference and sign up by July 23 to save $100 on super early bird prices!

Keep the Conversations Going

18 Mar

By Rory McCann, Marketing Manager & Conference Producer, LSN

Healthtech Partnering Week is off to the races! Digital RESI March has wrapped up with 1,000+ meetings in 3 days and leads into a triple-threat partnering experience consisting of 4D Meets AI, Access China Spring Forum (free), and Longevity, Health & Innovation taking place consecutively March 18-19.

It’s not too late to sign up and get involved in any of these three events! To learn more, visit the Healthtech Partnering Week website. Each conference offers unique opportunities suited for specific technology assets and market solutions. We hope you’ll join us and round out your RESI partnering with the full Healthtech Partnering Week experience!





Introducing Healthtech Partnering Week Innovator’s Pitch Challenge Finalists

11 Mar

By Claire Jeong, Chief Conference Officer, Vice President of Investor Research, Asia BD, LSN

claireLife Science Nation (LSN) is pleased to announce next week’s Healthtech Partnering Week (HPW) Innovator’s Pitch Challenge finalists. The Innovator’s Pitch Challenge is an opportunity for early-stage companies to gain additional exposure to conference attendees, pitch directly to a panel of relevant investors, and participate in a live Q&A session.

Pitching opportunities at LSN partnering events are popular events for startups and investors alike. They provide exposure and experience to the companies, while providing investors with insight into the latest technology organized by sector and interest. Check out our finalists and select a logo to learn more about their participation. Registration is still open, so don’t miss out and sign up today!

Innovator’s Pitch Challenge Finalists

 

%d bloggers like this: